Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 1

End of life care in chronic obstructive pulmonary disease: in search of a good death

Authors Anna Spathis, Sara Booth

Published 7 March 2008 Volume 2008:3(1) Pages 11—29

DOI http://dx.doi.org/10.2147/COPD.S698

Anna Spathis, Sara Booth

Palliative Care Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, England, UK

Abstract: Chronic obstructive pulmonary disease (COPD) is an incurable, progressive illness that is the fourth commonest cause of death worldwide. Death tends to occur after a prolonged functional decline associated with uncontrolled symptoms, emotional distress and social isolation. There is increasing evidence that the end of life needs of those with advanced COPD are not being met by existing services. Many barriers hinder the provision of good end of life care in COPD, including the inherent difficulties in determining prognosis. This review provides an evidence-based approach to overcoming these barriers, summarising current evidence and highlighting areas for future research. Topics include end of life needs, symptom control, advance care planning, and service development to improve the quality of end of life care.

Keywords: chronic obstructive pulmonary disease (MeSH), palliative care (MeSH), dyspnoea (MeSH), advance care planning (MeSH)

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Improvement of pharmacokinetic and antitumor activity of layered double hydroxide nanoparticles by coating with PEGylated phospholipid membrane

Yan MN, Zhang ZG, Cui SM, Lei M, Zeng K, Liao YH, Chu WJ, Deng YH, Zhao CS

International Journal of Nanomedicine 2014, 9:4867-4878

Published Date: 21 October 2014

Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy

Foody JM, Toth PP, Tomassini JE, Sajjan S, Ramey DR, Neff D, Tershakovec AM, Hu H, Tunceli K

Vascular Health and Risk Management 2013, 9:719-727

Published Date: 15 November 2013

Update on the role of antipsychotics in the treatment of Tourette syndrome

Huys D, Hardenacke K, Poppe P, Bartsch C, Baskin B, Kuhn J

Neuropsychiatric Disease and Treatment 2012, 8:95-104

Published Date: 12 March 2012

Factors associated with good self-rated health and quality of life in subjects with self-reported COPD

Arne M, Lundin F, Boman G, Janson C, Janson S, Emtner M

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:511-519

Published Date: 7 October 2011

The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD

Barbara P Yawn, Ibrahim Raphiou, Judith S Hurley, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:165-178

Published Date: 1 June 2010

Arterial pulmonary hypertension in noncardiac intensive care unit

Mykola V Tsapenko, Arseniy V Tsapenko, Thomas BO Comfere, Girish K Mour, Sunil V Mankad, Ognjen Gajic

Vascular Health and Risk Management 2008, 4:1043-1060

Published Date: 10 October 2008

Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium

Cristoforo Incorvaia, Gian Galeazzo Riario-Sforza, Chiara Pravettoni, Mona-Rita Yacoub, Franco Frati

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:123-126

Published Date: 7 March 2008

Erratum

Shapiro MA, Chang YL, Munson SK, et al.

Neuropsychiatric Disease and Treatment 2008, 4:319-319

Published Date: 8 February 2008